Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by jopatcloon Nov 01, 2024 8:01am
67 Views
Post# 36291938

RE:TCT2024

RE:TCT2024@Brotherlightness I feel and believe we have at least a 10 bagger here and just a hunch but i think a lot of the recent sentiment turned "Fud" is just flippers trying to spin this and grab cheap shares to buy back in. There's a lot of "rumors" swirling about, Dr. Adams is a visionary with Ventripoint I think they know more about the Ventripoint tech than the whiners on this board. See very positive FDA V4.0 and Sales at any time now Insiders know! and now
*Dr.Brian Soriano MD, FASE | Cardiologist, Associate Professor, Cardiology, and Adjunct Associate Professor, Radiology, Seattle Children’s Hospital
*Dr Skinner, Consultant Paediatric Cardiologist from the University Hospital Leicester.
*Dr. Laser is the Deputy Director and Senior Physician from the Department of Pediatric Cardiology and Congenital Heart Defects of Herz-und Diabeteszentrium North Rhine-Westfalia .
*Dr. Howard Leong-Poi is Head of the Division of Cardiology, as well as the Medical Director of the Heart and Vascular Program at St. Michael’s Hospital in Toronto, Ontario.
*Dr.Luc Mertens Medical Director of Echocardiography The Hospital for Sick Children, Toronto, CA
*Dr.Brian Soriano MD, FASE | Cardiologist, Associate Professor, Cardiology, and Adjunct Associate Professor, Radiology, Seattle Children’s Hospital
*Dr.Jeffrey Soble on the Ventripoint website “Our goal is that by working together, we can ultimately provide reliable and effective tools to clinicians globally.” Jeffrey Soble, MD CEO ASCEND
https://ventripoint.com/ For those who continue their negative posts about Ventripoint like better out then in! Ventripoint selected as a trusted solution for cardiac imaging; presented at Take Heart conference https://www.youtube.com/watch?app=desktop&v=Ucu6uGRMtEs The BEST automation and analysis on the PLANET GEN3EHO On website Ascend https://ascendcv.com/ #vpt
<< Previous
Bullboard Posts
Next >>